To the Editor Dr Anderson and colleagues1 reported that leaders in many AMCs received substantial annual compensation for serving on the boards of pharmaceutical companies. Regardless of the form and amount of the compensation; whether it is retained by the individual AMC leader or donated to the AMC or to charity; whether it is fully disclosed; and no matter what the good intentions of the leaders might have been in accepting an affiliation with a pharmaceutical company, such ties are a real (never a “potential”) conflict of interest and should be totally eliminated.
Relman AS. Potential Conflicts of Interest for Academic Medical Center Leaders. JAMA. 2014;312(5):558. doi:10.1001/jama.2014.7569